<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>266-HYDROCORTISONE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="HYDROCORTISONE" rxcui="5492">
<ATC code="A01AC03" />
<ATC code="A07EA02" />
<ATC code="D07XA01" />
<ATC code="H02AB09" />
<ATC code="S01BA02" />
<ATC code="S01CB03" />
<ATC code="S02BA01" />
<ATC code="D07AC16" />
<ATC code="D07CA01" />
<ATC code="S01CA03" />
<ATC code="S02CA03" />
<ATC code="S03CA04" />
<ATC code="D07BA04" />
<ATC code="S01BB01" />
<ATC code="D07AB11" />
<ATC code="D07AB02" />
<ATC code="D07BB04" />
<ATC code="R01AD60" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="ENZYMATIC INDUCERS" code="N03-J05-001" /></DRUG2>
<DESCRIPTION>Risk of decrease of the effectiveness of the hydrocortisone (increase of its metabolism); the consequences are serious when the hydrocortisone is administered in replacement therapy or in case of transplants</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Clinical and biological monitoring; adjustment of the dosage of the hydrocortisone during the time it is taken with the enzymatic inducer and after the enzymatic inducer is stopped. </COMMENT>
</INTERACTION>
</INTERACTIONS>
